1. Home
  2. ZKH vs THW Comparison

ZKH vs THW Comparison

Compare ZKH & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZKH

ZKH Group Limited

HOLD

Current Price

$3.43

Market Cap

571.2M

Sector

N/A

ML Signal

HOLD

THW

abrdn World Healthcare Fund Shares of Beneficial Interest

HOLD

Current Price

$12.65

Market Cap

514.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZKH
THW
Founded
1998
2015
Country
China
United States
Employees
N/A
N/A
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
571.2M
514.7M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
ZKH
THW
Price
$3.43
$12.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
116.2K
149.9K
Earning Date
03-17-2026
01-01-0001
Dividend Yield
N/A
10.76%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,236,195,501.00
N/A
Revenue This Year
$2.58
N/A
Revenue Next Year
$10.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$9.76
52 Week High
$3.90
$14.89

Technical Indicators

Market Signals
Indicator
ZKH
THW
Relative Strength Index (RSI) 49.88 47.39
Support Level $3.36 $12.40
Resistance Level $3.50 $13.03
Average True Range (ATR) 0.08 0.18
MACD -0.01 -0.03
Stochastic Oscillator 28.89 39.69

Price Performance

Historical Comparison
ZKH
THW

About ZKH ZKH Group Limited

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

About THW abrdn World Healthcare Fund Shares of Beneficial Interest

Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.

Share on Social Networks: